Willingness to Pay for Childhood Malaria Vaccine Among Caregivers of Under-Five Children in Northwest Ethiopia
Received 28 December 2020
Accepted for publication 26 February 2021
Published 15 March 2021 Volume 2021:13 Pages 165—174
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Prof. Dr. Dean Smith
Yohannes Wagnew,1 Tsega Hagos,2 Berhanemeskel Weldegerima,3 Ayal Debie2
1University of Gondar Comprehensive and Specialized Referral Hospital, University of Gondar, Gondar, Ethiopia; 2Department of Health Systems and Policy, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia; 3Department of Pharmaceutics, School of Pharmacy, College of Medical and Health Sciences, University of Gondar, Gondar, Ethiopia
Correspondence: Ayal Debie
University of Gondar, P.O. Box: 196, Gondar, Ethiopia
Email [email protected]
Background: Malaria, a protozoan disease caused by the genus Plasmodium, is responsible for serious illnesses and death across the world. RTS, S/AS01 (Mosquirix™) is a recombinant protein-based malaria vaccine valuable for the prevention and control of the disease. However, studies done so far on the willingness to pay (WTP) malaria vaccine have been inadequate to inform policy-makers.
Methods: A community-based cross-sectional study was conducted to assess the WTP for childhood malaria vaccine and associated factors among caregivers of under-five children from February to April 2019 in West Dembia district. A multistage stratified systematic sampling technique was used, and the contingent valuation method was used to estimate caregivers’ willingness to pay for the vaccine. AOR with 95% CI and less than 0.05 p-values were used to declare factors associated with WTP.
Results: Overall, 60.6% (95% CI: 56.60, 64.40%) of caregivers of under-five children were WTP for the childhood malaria vaccine at a price of US$ 23.11 per full doses. Urban residence (AOR=1.78, 95% CI: 1.04, 3.04), educational status (AOR=3.27; 95% CI: 1.07, 9.94) and vaccination experience for children (AOR= 2.12; 95% CI: 1.29, 3.48) were positively associated with the WTP. WTP for the vaccine was higher among rich households (AOR=3.15; 95% CI: 1.90, 5.22), caregivers who had the previous history of malaria attack (AOR=2.62; 95% CI: 1.68, 4.08), households with fewer members (AOR=1.59; 95% CI: 1.06, 2.40), and families more knowledgeable about malaria prevention and control (AOR=3.56; 95% CI: 1.83, 6.93) compared with their counterparts.
Conclusion: The majority of the participants were WTP for the childhood malaria vaccine. A significant rise in willingness to purchase was observed at price below the profile price. Thus, it is of great value to policy-makers to understand the price sensitivity before setting the price of the vaccine.
Keywords: willingness to pay, malaria vaccine, under-five children, northwest, Ethiopia
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]